Cargando…

Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for the Screening of Diabetic Neuropathy in Primary Care. Decoding Study (Dermal Electrochemical Conductance in Diabetic Neuropathy)

Diabetes mellitus (DM) is the leading cause of polyneuropathy in the Western world. Diabetic neuropathy (DNP) is the most common complication of diabetes and is of great clinical significance mainly due to the pain and the possibility of ulceration in the lower limbs. Early detection of neuropathy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabré, Juan J., Mur, Teresa, Costa, Bernardo, Barrio, Francisco, López-Moya, Charo, Sagarra, Ramon, García-Barco, Montserrat, Vizcaíno, Jesús, Bonaventura, Immaculada, Ortiz, Nicolau, Flores-Mateo, Gemma, Solà-Morales, Oriol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572367/
https://www.ncbi.nlm.nih.gov/pubmed/31052426
http://dx.doi.org/10.3390/jcm8050598
_version_ 1783427624123498496
author Cabré, Juan J.
Mur, Teresa
Costa, Bernardo
Barrio, Francisco
López-Moya, Charo
Sagarra, Ramon
García-Barco, Montserrat
Vizcaíno, Jesús
Bonaventura, Immaculada
Ortiz, Nicolau
Flores-Mateo, Gemma
Solà-Morales, Oriol
author_facet Cabré, Juan J.
Mur, Teresa
Costa, Bernardo
Barrio, Francisco
López-Moya, Charo
Sagarra, Ramon
García-Barco, Montserrat
Vizcaíno, Jesús
Bonaventura, Immaculada
Ortiz, Nicolau
Flores-Mateo, Gemma
Solà-Morales, Oriol
author_sort Cabré, Juan J.
collection PubMed
description Diabetes mellitus (DM) is the leading cause of polyneuropathy in the Western world. Diabetic neuropathy (DNP) is the most common complication of diabetes and is of great clinical significance mainly due to the pain and the possibility of ulceration in the lower limbs. Early detection of neuropathy is essential in the medical management of this complication. Early unmyelinated C-fiber dysfunction is one of the typical findings of diabetic neuropathy and the first clinical manifestation of dysfunction indicating sudomotor eccrine gland impairment. In order to assess newly developed technology for the measurement of dermal electrochemical conductance (DEC), we analyzed the feasibility and effectiveness of DEC (quantitative expression of sudomotor reflex) as a screening test of DNP in primary health care centers. The study included 197 people (with type 2 diabetes, prediabetes and normal tolerance) who underwent all the protocol tests and electromyography (EMG). On comparing DEC with EMG as the gold standard, the area under the receiver operating characteristic (ROC) curve (AUC, area under the curve) was 0.58 in the whole sample, AUC = 0.65 in the diabetes population and AUC = 0.72 in prediabetes, being irrelevant in subjects without glucose disturbances (AUC = 0.47). Conclusions: In usual clinical practice, DEC is feasible, with moderate sensitivity but high specificity. It is also easy to use and interpret and requires little training, thereby making it a good screening test in populations with diabetes and prediabetes. It may also be useful in screening general populations at risk of neuropathy.
format Online
Article
Text
id pubmed-6572367
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65723672019-06-18 Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for the Screening of Diabetic Neuropathy in Primary Care. Decoding Study (Dermal Electrochemical Conductance in Diabetic Neuropathy) Cabré, Juan J. Mur, Teresa Costa, Bernardo Barrio, Francisco López-Moya, Charo Sagarra, Ramon García-Barco, Montserrat Vizcaíno, Jesús Bonaventura, Immaculada Ortiz, Nicolau Flores-Mateo, Gemma Solà-Morales, Oriol J Clin Med Article Diabetes mellitus (DM) is the leading cause of polyneuropathy in the Western world. Diabetic neuropathy (DNP) is the most common complication of diabetes and is of great clinical significance mainly due to the pain and the possibility of ulceration in the lower limbs. Early detection of neuropathy is essential in the medical management of this complication. Early unmyelinated C-fiber dysfunction is one of the typical findings of diabetic neuropathy and the first clinical manifestation of dysfunction indicating sudomotor eccrine gland impairment. In order to assess newly developed technology for the measurement of dermal electrochemical conductance (DEC), we analyzed the feasibility and effectiveness of DEC (quantitative expression of sudomotor reflex) as a screening test of DNP in primary health care centers. The study included 197 people (with type 2 diabetes, prediabetes and normal tolerance) who underwent all the protocol tests and electromyography (EMG). On comparing DEC with EMG as the gold standard, the area under the receiver operating characteristic (ROC) curve (AUC, area under the curve) was 0.58 in the whole sample, AUC = 0.65 in the diabetes population and AUC = 0.72 in prediabetes, being irrelevant in subjects without glucose disturbances (AUC = 0.47). Conclusions: In usual clinical practice, DEC is feasible, with moderate sensitivity but high specificity. It is also easy to use and interpret and requires little training, thereby making it a good screening test in populations with diabetes and prediabetes. It may also be useful in screening general populations at risk of neuropathy. MDPI 2019-05-01 /pmc/articles/PMC6572367/ /pubmed/31052426 http://dx.doi.org/10.3390/jcm8050598 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cabré, Juan J.
Mur, Teresa
Costa, Bernardo
Barrio, Francisco
López-Moya, Charo
Sagarra, Ramon
García-Barco, Montserrat
Vizcaíno, Jesús
Bonaventura, Immaculada
Ortiz, Nicolau
Flores-Mateo, Gemma
Solà-Morales, Oriol
Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for the Screening of Diabetic Neuropathy in Primary Care. Decoding Study (Dermal Electrochemical Conductance in Diabetic Neuropathy)
title Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for the Screening of Diabetic Neuropathy in Primary Care. Decoding Study (Dermal Electrochemical Conductance in Diabetic Neuropathy)
title_full Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for the Screening of Diabetic Neuropathy in Primary Care. Decoding Study (Dermal Electrochemical Conductance in Diabetic Neuropathy)
title_fullStr Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for the Screening of Diabetic Neuropathy in Primary Care. Decoding Study (Dermal Electrochemical Conductance in Diabetic Neuropathy)
title_full_unstemmed Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for the Screening of Diabetic Neuropathy in Primary Care. Decoding Study (Dermal Electrochemical Conductance in Diabetic Neuropathy)
title_short Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for the Screening of Diabetic Neuropathy in Primary Care. Decoding Study (Dermal Electrochemical Conductance in Diabetic Neuropathy)
title_sort feasibility and effectiveness of electrochemical dermal conductance measurement for the screening of diabetic neuropathy in primary care. decoding study (dermal electrochemical conductance in diabetic neuropathy)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572367/
https://www.ncbi.nlm.nih.gov/pubmed/31052426
http://dx.doi.org/10.3390/jcm8050598
work_keys_str_mv AT cabrejuanj feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy
AT murteresa feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy
AT costabernardo feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy
AT barriofrancisco feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy
AT lopezmoyacharo feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy
AT sagarraramon feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy
AT garciabarcomontserrat feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy
AT vizcainojesus feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy
AT bonaventuraimmaculada feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy
AT ortiznicolau feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy
AT floresmateogemma feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy
AT solamoralesoriol feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy
AT feasibilityandeffectivenessofelectrochemicaldermalconductancemeasurementforthescreeningofdiabeticneuropathyinprimarycaredecodingstudydermalelectrochemicalconductanceindiabeticneuropathy